They demonstrate that interventions that inhibit the production and or effector functions of CHI3L1 can diminish the ability of CHI3L1 to block tumor cell death and augment the expression of IFNα/β, ChemR23, phosphorylated cofilin and LimK2 (29). The gene discussed is CMKLR1; the disease is neoplasm.